U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H17N5O2
Molecular Weight 251.285
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIMETHAZAN

SMILES

CN(C)CCN1C=NC2=C1C(=O)N(C)C(=O)N2C

InChI

InChIKey=CMKUGKVVUUGBHJ-UHFFFAOYSA-N
InChI=1S/C11H17N5O2/c1-13(2)5-6-16-7-12-9-8(16)10(17)15(4)11(18)14(9)3/h7H,5-6H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C11H17N5O2
Molecular Weight 251.285
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Dimethazan is a caffeine derivative. Dimethazan differs from caffeine by the replacement of the third methyl group. Dimethazan possesses antidepressant and diuretic properties. Dimethazan, administered intravenously to geriatric patients, produced respiratory and cerebral stimulation in the majority of cases. The clinical utilization of the respiratory stimulatory effect was confirmed in a patient markedly depressed with chlorpromazine. Oral administration to patients hospitalized for treatment of mental and physical depression indicated a dual effect: central nervous system stimulation and sedation. It is safe and well tolerated with none of the shortcomings of other caffeine preparations.

Approval Year

PubMed

PubMed

TitleDatePubMed
Central nervous system stimulation and sedation with dimethazan.
1958-08

Sample Use Guides

50 to 600 mg over a 2- to 4-minute period
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:46:34 GMT 2025
Edited
by admin
on Mon Mar 31 18:46:34 GMT 2025
Record UNII
H943V308AD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIMETHAZAN [MI]
Preferred Name English
DIMETHAZAN
INN   MI  
INN  
Official Name English
7-(2-DIMETHYLAMINOETHYL)THEOPHYLLINE
Systematic Name English
dimethazan [INN]
Common Name English
Code System Code Type Description
MERCK INDEX
m696
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY Merck Index
SMS_ID
100000082661
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-266-1
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
PUBCHEM
10612
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
DRUG CENTRAL
3731
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
CAS
519-30-2
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
WIKIPEDIA
Dimethazan
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
EPA CompTox
DTXSID10199858
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
EVMPD
SUB07171MIG
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
ChEMBL
CHEMBL1739955
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
FDA UNII
H943V308AD
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
NCI_THESAURUS
C169911
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
INN
778
Created by admin on Mon Mar 31 18:46:34 GMT 2025 , Edited by admin on Mon Mar 31 18:46:34 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY